Skip to main content
SpringerLink
Log in
Book cover

Personalized Medicine as Innovation

What Can Germany Learn from the USA

  • Book
  • © 2019

Overview

Authors:
  1. Katharina Kichko

    1. Greifswald, Germany

    View author publications

    You can also search for this author in PubMed   Google Scholar

  • Publication in the field of economic sciences
  • Includes supplementary material: sn.pub/extras

Part of the book series: Gesundheitsmanagement und Gesundheitsökonomik (GMGOE)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (8 chapters)

  1. Front Matter

    Pages I-XXV
    Download chapter PDF

  2. Introduction

    • Katharina Kichko
    Pages 1-8

  3. Background

    • Katharina Kichko
    Pages 9-50

  4. Methodology

    • Katharina Kichko
    Pages 51-58

  5. The United States of America as Early Knower

    • Katharina Kichko
    Pages 59-196

  6. Germany - a Follower or a Laggard

    • Katharina Kichko
    Pages 197-253

  7. Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.

    • Katharina Kichko
    Pages 255-272

  8. Personalized Medicine in European Countries

    • Katharina Kichko
    Pages 273-275

  9. Conclusion

    • Katharina Kichko
    Pages 277-295

  10. Back Matter

    Pages 297-354
    Download chapter PDF
Back to top

Keywords

About this book

Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. – as early knower – have the most projects as well as personalized drugs and therapies, while Germany – as a follower – has a significant number of projects and personalized products and more to come in future.

Authors and Affiliations

  • Greifswald, Germany

    Katharina Kichko

About the author

Katharina Kichko has written this book within her PhD program at the University of Greifswald.

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation